The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial
Open accessAbstract
IMPORTANCE: In retrospective studies, 68Ga-PSMA-11 positron emission tomographic (PET) imaging improves detection of biochemically recurrent prostate cancer compared with conventional imaging. OBJECTIVE: To assess 68Ga-PSMA-11 PET accuracy in a prospective multicenter trial. DESIGN, SETTING, AND PARTICIPANTS: In this single-arm prospective trial conducted at University of California, San Francisco and University of California, Los Angeles, 635 patients with biochemically recurrent prostate cancer after prostatectomy (n = 262, 41%), radiation therapy (n = 169, 27%), or both (n = 204, 32%) underwent 68Ga-PSMA-11 PET. Presence of prostate cancer was recorded by 3 blinded readers on a per-patient and per-region base. Lesions were validated by histopathologic analysis and a composite reference standard. MAIN OUTCOMES AND MEASURES: Endpoints were positive predictive value (PPV), detection rate, interreader reproducibility, and safety. RESULTS: A total of 635 men were enrolled with a median age of 69 years (range, 44-95 years). On a per-patient basis, PPV was 0.84 (95% CI, 0.75-0.90) by histopathologic validation (primary endpoint, n = 87) and 0.92 (95% CI, 0.88-0.95) by the composite reference standard (n = 217). 68Ga-PSMA-11 PET localized recurrent prostate cancer in 475 of 635 (75%) patients; detection rates significantly increased with prostate-specific antigen (PSA): 38% for <0.5 ng/mL (n = 136), 57% for 0.5 to <1.0 ng/mL (n = 79), 84% for 1.0 to <2.0 ng/mL (n = 89), 86% for 2.0 to <5.0 ng/mL (n = 158), and 97% for ≥5.0 ng/mL (n = 173, P < .001). Interreader reproducibility was substantial (Fleiss κ, 0.65-0.78). There were no serious adverse events associated with 68Ga-PSMA-11 administration. PET-directed focal therapy alone led to a PSA drop of 50% or more in 31 of 39 (80%) patients. CONCLUSIONS AND RELEVANCE: Using blinded reads and independent lesion validation, we establish high PPV for 68Ga-PSMA-11 PET, detection rate and interreader agreement for localization of recurrent prostate cancer. TRIAL REGISTRATION: ClinicalTrials.gov identifiers: NCT02940262 and NCT03353740.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148
Two-sided confidence intervals for the single proportion: comparison of seven methods
Newcombe, R. G. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e · Cited by 5,107
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
Pound, C. R. (1999) · JAMA · doi:10.1001/jama.281.17.1591 · Cited by 3,071
Roach, M., Hanks, G., Thames, H., Schellhammer, P., Shipley, W. U., Sokol, G. H., & Sandler, H. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.04.029 · Cited by 2,749
Higgins (2002) · doi:10.1002/(issn)1097-0258 · Cited by 1,248
Perera, M., Papa, N., Christidis, D., Wetherell, D., Hofman, M. S., Murphy, D. G., Bolton, D., & Lawrentschuk, N. (2016) · European Urology · doi:10.1016/j.eururo.2016.06.021 · Cited by 1,007
Eiber, M., Maurer, T., Souvatzoglou, M., Beer, A. J., Ruffani, A., Haller, B., Graner, F.-P., Kübler, H., Haberhorn, U., Eisenhut, M., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.154153 · Cited by 994
Self-citationAfshar-Oromieh, A., Avtzi, E., Giesel, F. L., Holland-Letz, T., Linhart, H. G., Eder, M., Eisenhut, M., Boxler, S., Hadaschik, B. A., Kratochwil, C., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2949-6 · Cited by 964
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
Fendler, W. P., Eiber, M., Beheshti, M., Bomanji, J., Ceci, F., Cho, S., Giesel, F., Haberkorn, U., Hope, T. A., Kopka, K., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3670-z · Cited by 750
Self-citationEiber, M., Herrmann, K., Calais, J., Hadaschik, B., Giesel, F. L., Hartenbach, M., Hope, T., Reiter, R., Maurer, T., Weber, W. A., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.198119 · Cited by 626
Self-citationMorigi, J. J., Stricker, P. D., van Leeuwen, P. J., Tang, R., Ho, B., Nguyen, Q., Hruby, G., Fogarty, G., Jagavkar, R., Kneebone, A., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.160382 · Cited by 571
Self-citationAfshar-Oromieh, A., Holland-Letz, T., Giesel, F. L., Kratochwil, C., Mier, W., Haufe, S., Debus, N., Eder, M., Eisenhut, M., Schäfer, M., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3711-7 · Cited by 507
Han, S., Woo, S., Kim, Y. J., & Suh, C. H. (2018) · European Urology · doi:10.1016/j.eururo.2018.03.030 · Cited by 331
Sheikhbahaei, S., Afshar-Oromieh, A., Eiber, M., Solnes, L. B., Javadi, M. S., Ross, A. E., Pienta, K. J., Allaf, M. E., Haberkorn, U., Pomper, M. G., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3780-7 · Cited by 295
Self-citationCeci, F., Uprimny, C., Nilica, B., Geraldo, L., Kendler, D., Kroiss, A., Bektic, J., Horninger, W., Lukas, P., Decristoforo, C., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3078-6 · Cited by 262
Methods for Calculating Sensitivity and Specificity of Clustered Data: A Tutorial
Genders, T. S. S., Spronk, S., Stijnen, T., Steyerberg, E. W., Lesaffre, E., & Hunink, M. G. M. (2012) · Radiology · doi:10.1148/radiol.12120509 · Cited by 258
von Eyben, F. E., Picchio, M., von Eyben, R., Rhee, H., & Bauman, G. (2018) · European Urology Focus · doi:10.1016/j.euf.2016.11.002 · Cited by 257
Deppen, S. A., Liu, E., Blume, J. D., Clanton, J., Shi, C., Jones-Jackson, L. B., Lakhani, V., Baum, R. P., Berlin, J., Smith, G. T., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.163865 · Cited by 236
Nanni, C., Zanoni, L., Pultrone, C., Schiavina, R., Brunocilla, E., Lodi, F., Malizia, C., Ferrari, M., Rigatti, P., Fonti, C., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3329-1 · Cited by 227
68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
Rauscher, I., Maurer, T., Fendler, W. P., Sommer, W. H., Schwaiger, M., & Eiber, M. (2016) · Cancer Imaging · doi:10.1186/s40644-016-0072-6 · Cited by 208
Self-citationCalais, J., Fendler, W. P., Eiber, M., Gartmann, J., Chu, F., Nickols, N. G., Reiter, R. E., Rettig, M. B., Marks, L. S., Ahlering, T. E., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.202945 · Cited by 170
Self-citationJilg, C. A., Drendel, V., Rischke, H. C., Beck, T. I., Vach, W., Schaal, K., Wetterauer, U., Schultze‐Seemann, W., & Meyer, P. T. (2017) · Theranostics · doi:10.7150/thno.18421 · Cited by 144
Fendler, W. P., Calais, J., Allen-Auerbach, M., Bluemel, C., Eberhardt, N., Emmett, L., Gupta, P., Hartenbach, M., Hope, T. A., Okamoto, S., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.190827 · Cited by 141
Self-citationGrubmüller, B., Baltzer, P., D’Andrea, D., Korn, S. M., Haug, A. R., Hacker, M., Grubmüller, K. H., Goldner, G. M., Wadsak, W., Pfaff, S., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3858-2 · Cited by 119
Einspieler, I., Rauscher, I., Düwel, C., Kroenke, M., Rischpler, C., Habl, G., Dewes, S., Ott, A., Wester, H., Schwaiger, M., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.184457 · Cited by 83
Self-citationImpact of 68Ga-Prostate-Specific Membrane Antigen PET/CT on Prostate Cancer Management
Afaq, A., Alahmed, S., Chen, S.-H., Lengana, T., Haroon, A., Payne, H. A., Ahmed, H. U., Punwani, S., Sathekge, M. M., & Bomanji, J. B. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.192625 · Cited by 69
Lake, S. T., Greene, K. L., Westphalen, A. C., Behr, S. C., Zagoria, R. J., Small, E. J., Carroll, P. R., & Hope, T. A. (2017) · EJNMMI Research · doi:10.1186/s13550-017-0327-7 · Cited by 42
Self-citationFendler, W. P., Barrio, M. J., Spick, C., Allen-Auerbach, M., Ambrosini, V., Benz, M., Bluemel, C., Grewal, R. K., Lapa, C., Miederer, M., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.179192 · Cited by 37
Self-citationMiller, M. P., Kostakoğlu, L., Pryma, D. A., Yu, J. Q., Chau, A., Perlman, E. S., Clarke, B., Rosen, D., & Ward, P. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.188375 · Cited by 35
Cited by
Hofman, M. S., Lawrentschuk, N., Francis, R. J., Tang, C., Vela, I., Thomas, P., Rutherford, N., Martin, J. M., Frydenberg, M., Shakher, R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30314-7 · Cited by 2,040
Calais, J., Ceci, F., Eiber, M., Hope, T. A., Hofman, M. S., Rischpler, C., Bach-Gansmo, T., Nanni, C., Savir-Baruch, B., Elashoff, D., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30415-2 · Cited by 476
Self-citationEmmett, L., Buteau, J., Papa, N., Moon, D., Thompson, J., Roberts, M. J., Rasiah, K., Pattison, D. A., Yaxley, J., Thomas, P., et al. (2021) · European Urology · doi:10.1016/j.eururo.2021.08.002 · Cited by 430
Self-citationRadiotheranostics in oncology: current challenges and emerging opportunities
Bodei, L., Herrmann, K., Schöder, H., Scott, A. M., & Lewis, J. S. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00652-y · Cited by 414
Self-citationPSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
Fendler, W. P., Eiber, M., Beheshti, M., Bomanji, J., Calais, J., Ceci, F., Cho, S. Y., Fanti, S., Giesel, F. L., Goffin, K., et al. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-06089-w · Cited by 410
Self-citation
Metadata
- Authors
- Fendler, W. P., Calais, J., Eiber, M., Flavell, R. R., Mishoe, A., Feng, F. Y., Nguyen, H. G., Reiter, R. E., Rettig, M. B., Okamoto, S., Emmett, L., Zacho, H. D., Ilhan, H., Wetter, A., Rischpler, C., Schoder, H., Burger, I. A., Gartmann, J., Smith, R., Small, E. J., Slavik, R., Carroll, P. R., Herrmann, K., Czernin, J., & Hope, T. A.
- Venue
- JAMA Oncology
- Publisher
- American Medical Association (AMA)
- Published
- 2019-06-01
- Volume
- 5
- Issue
- 6
- Pages
- 856
- ISSN
- 2374-2437 (ISSN-L)
- OpenAlex
- W2924617625
- Cited by
- 779
- References
- 29
- FWCI
- 61.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.